| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) | 
|---|
| 12/24/1991 | US5075138 Supplying cold air to area where powder and coating collide, hot air separately | 
| 12/24/1991 | US5075115 Process for polymerizing poly(lactic acid) | 
| 12/24/1991 | US5075114 Taste masking and sustained release coatings for pharmaceuticals | 
| 12/24/1991 | US5075109 Administering in encapsulated form | 
| 12/24/1991 | US5075105 Composition for treatment of progressive myopia | 
| 12/24/1991 | US5075104 Carbopol | 
| 12/24/1991 | US5074857 Bolus for releasing a biologically active substance into a liquid environment | 
| 12/24/1991 | CA1293449C Controlled release drug preparation | 
| 12/24/1991 | CA1293448C Ophthalmic solutions and methods for improving the comfort and safety of contact lenses | 
| 12/24/1991 | CA1293446C Therapeutic agents in the form of submicroscopic particles against leishmaniasis and pharmaceutical compositions containing them | 
| 12/24/1991 | CA1293445C Cephalosporin injection | 
| 12/24/1991 | CA1293443C Controlled release of macromolecular polypetides | 
| 12/22/1991 | CA2043992A1 Use of cytokine-containing aerosols and the cytokine-containing aerosols | 
| 12/21/1991 | WO1991019474A1 Transdermal administration of buprenorphine | 
| 12/21/1991 | CA2085126A1 Transdermal administration of buprenorphine | 
| 12/21/1991 | CA2044979A1 Coated veterinary implants | 
| 12/20/1991 | WO1991019563A1 Releasably bound active materials | 
| 12/20/1991 | WO1991019480A1 Pharmaceutical preparation | 
| 12/20/1991 | CA2085100A1 Pharmaceutical preparation | 
| 12/20/1991 | CA2084676A1 Releasably bound active materials | 
| 12/20/1991 | CA2044841A1 Releasably bound active materials | 
| 12/18/1991 | EP0462067A1 Gemfibrozil formulations | 
| 12/18/1991 | EP0462066A1 Amorphous gemfibrozil | 
| 12/18/1991 | EP0462015A1 Process for coating drugs with pH sensitive polymers | 
| 12/18/1991 | EP0462003A1 Microcapsules containing an oily liquid | 
| 12/18/1991 | EP0461930A1 A crystallization method to improve crystal structure and size | 
| 12/18/1991 | EP0461662A1 Process for preparing liposomes | 
| 12/18/1991 | EP0461630A2 Production process of microspheres | 
| 12/18/1991 | EP0461559A2 Non active substance containing liposomes for the treatment of atherosclerosis | 
| 12/18/1991 | EP0461505A1 Spray containing nitroglycerin | 
| 12/18/1991 | EP0461497A1 Use of selective hydrogenated styrol-butadien-copolymers in cosmetic and pharmaceutical compositions | 
| 12/18/1991 | EP0461333A1 Phospholipidic liposomes containing active principles and a process for the production thereof | 
| 12/18/1991 | EP0461290A1 Capsules with a liquid content | 
| 12/18/1991 | EP0461225A1 Circumvention of human tumor drug resistance | 
| 12/18/1991 | EP0461108A1 Partially fused peptide pellet. | 
| 12/18/1991 | EP0442962A4 Liposomal radiologic contrast agents | 
| 12/18/1991 | CN1057004A Preparation of antimycotic | 
| 12/18/1991 | CN1057002A Preparation of compound rifampin (rfp) capsules | 
| 12/18/1991 | CN1057001A Preparation of enteritislin capsules | 
| 12/18/1991 | CN1015106B Process for preparing crystalline hydrate of oral cephalosporin | 
| 12/17/1991 | US5073546 Antiinflammatory, analgesic, anticholesterol agent; psychological and nervous disorders | 
| 12/17/1991 | US5073543 Controlled release formulations of trophic factors in ganglioside-lipsome vehicle | 
| 12/17/1991 | US5073539 Transdermal administration of zwitterionic drugs | 
| 12/17/1991 | US5073384 Containing simethicone; antiflatulents | 
| 12/17/1991 | US5073383 Inhibiting aggregation in fluorocarbon emulsions | 
| 12/17/1991 | US5073381 Sustained drug release | 
| 12/17/1991 | US5073380 Oral sustained release pharmaceutical formulation and process | 
| 12/17/1991 | US5073379 Continuous preparation of solid pharmaceutical forms | 
| 12/17/1991 | US5073377 Method of preparing oral dosage forms with a granulating composition | 
| 12/17/1991 | US5073376 Tablets or capsules containing tartaric acid for treatment of metabolic disorders | 
| 12/17/1991 | US5073375 Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof | 
| 12/17/1991 | US5073374 Drug delivery with active material, water soluble excipient an d lubricant | 
| 12/17/1991 | US5073365 Clinical and personal care articles enhanced by lubricants and adjuvants | 
| 12/17/1991 | US5073276 Polymer article of manufacture | 
| 12/17/1991 | CA1293194C Medicine based on fenofibrate, and a method of preparing it | 
| 12/17/1991 | CA1293170C Process for the preparation of dispersible colloidal systems of a substance in the form of nanocapsules | 
| 12/16/1991 | WO1991019502A1 Intercellular adhesion mediators | 
| 12/16/1991 | CA2084888A1 Intercellular adhesion mediators | 
| 12/16/1991 | CA2044509A1 Amorphous gemfibrozil | 
| 12/15/1991 | WO1991019487A1 Polymeric films for forming capsule shells | 
| 12/15/1991 | WO1991019486A1 Stable aqueous drug suspensions | 
| 12/15/1991 | WO1991019485A1 Injectable slow-release galenical | 
| 12/15/1991 | WO1991019484A1 Injectable pharmaceutical composition | 
| 12/15/1991 | CA2087273A1 Polymeric films for forming capsule shells | 
| 12/15/1991 | CA2085342A1 Stable aqueous drug suspensions | 
| 12/15/1991 | CA2044371A1 Transdermal administration to humans & animals | 
| 12/14/1991 | WO1991019746A1 Fractionated agaroid compositions, their preparation, and use | 
| 12/14/1991 | CA2083496A1 Fractionated agaroid compositions, their preparation, and use | 
| 12/14/1991 | CA2044353A1 Production process of microspheres | 
| 12/14/1991 | CA2044290A1 Microcapsule containing oily liquid | 
| 12/14/1991 | CA2044184A1 Use of selectively hydrogenated styrene/butadiene copolymers in cosmetic and pharmaceutical compositions | 
| 12/13/1991 | CA2085245A1 Aminosteroids for ophthalmic use | 
| 12/12/1991 | WO1991018940A1 Branched polyanhydrides | 
| 12/12/1991 | WO1991018621A1 The combination of growth hormone and insulin-like growth factor-i enhances growth | 
| 12/12/1991 | WO1991018616A1 Composite molecular system for the contra-escalatory treatment of viral infections | 
| 12/12/1991 | WO1991018610A1 New use of glucose and a new solution of glucose | 
| 12/12/1991 | WO1991018590A1 Process for the manufacture of porous cellulose matrices | 
| 12/12/1991 | WO1991018572A1 Device for transdermal administration of drugs | 
| 12/12/1991 | WO1991018570A1 Therapeutically effective topical application of st1435 | 
| 12/12/1991 | CA2018825A1 Phospholipidic liposomes containing active principles and a process for the production thereof | 
| 12/12/1991 | CA2018750A1 Method for dispersion of stress at the time of tableting | 
| 12/11/1991 | EP0461085A1 Pharmaceutical and/or cosmetic preparation | 
| 12/11/1991 | EP0460921A2 Large intestinal dissociative hard capsules | 
| 12/11/1991 | EP0460720A2 A method of extruding liposomes | 
| 12/11/1991 | EP0460588A1 Manufacture process of fast-desintegrating film-formed administration forms | 
| 12/11/1991 | EP0460428A2 Segmented absorbable copolymer | 
| 12/11/1991 | EP0460232A1 Tumor cell growth inhibitor | 
| 12/11/1991 | EP0460205A1 Radiolabeled colloid compositions, their use and process for their preparation | 
| 12/11/1991 | EP0460185A1 Preparation of pharmaceutical and other matrix systems by solid-state dissolution | 
| 12/11/1991 | EP0460101A1 Immobilized cytokines | 
| 12/11/1991 | EP0460100A1 Liposome gel composition and method | 
| 12/11/1991 | EP0460080A1 Orally administerable calcium supplement for cattle. | 
| 12/11/1991 | EP0460064A1 Therapeutic aerosol formulations | 
| 12/11/1991 | EP0452334A4 Mucoadhesive carrier for delivery of therapeutical agent | 
| 12/11/1991 | EP0280737B1 Steroidal drug-containing preparation for external use | 
| 12/11/1991 | EP0218679B1 Aerosol compositions for nasal delivery of vitamin b 12 | 
| 12/11/1991 | CN1056812A Pharmaceutical preparation | 
| 12/10/1991 | US5071964 Having phosphatidylinositol lipid anchor; inhibit adhesion of T-cells to other lymphocytes by binding to them | 
| 12/10/1991 | US5071706 Oily, free-flowing, microcapsules | 
| 12/10/1991 | US5071704 Multilayer; reservoir, impervious membrane |